GSK3B and schizophrenia: They also compared post-mortem brains of patients with schizophrenia and control individuals, and also found a decrease in AKT1 protein and phosphorylated GSK3β in the hippocampus and frontal cortex of individuals with schizophrenia, pointing to AKT1 as a possible susceptibility marker for schizophrenia.